Results 21 to 30 of about 31,086 (166)

Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma

Caspian Journal of Internal Medicine, 2020
Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics.
Nazanin Bagherlou, Safar Farajnia, Saber Zahri, Ali Dastranj Tabrizi, Atefeh Nazari   +4 more
doaj  

Tuberculous peritonitis with elevated serum CA125 levels mimicking peritoneal cancer

Clinical and Experimental Obstetrics & Gynecology, 2020
Background: Tuberculosis can spread to the peritoneum through the gastrointestinal tract via mesenteric lymph nodes or directly from the blood, lymph, or fallopian tubes.
A. Taniwaki, Y. Hashiguchi, M. Yamauchi, M. Kasai, T. Fukuda, T. Ichimura, T. Yasui, T. Sumi   +7 more
doaj   +1 more source

Survivin and VEGF as novel biomarkers in diagnosis of endometriosis [PDF]

Journal of Medical Biochemistry, 2016
Background: The aim of this study was to investigate the role of peripheral blood markers as additional diagnostic tools to transvaginal ultrasound (TVU) findings in the diagnosis of endometriosis.
Aćimović Milena, Vidaković Snežana, Milić Nataša, Jeremić Katarina, Marković Miloš, Milošević-Đerić Ana, Lazović-Radonjić Gordana   +6 more
doaj  

Prognostic value of glycoprotein CA125 and their time-line changes in decompensated heart failure

Spanish Journal of Medicine, 2021
Introduction and objectives: Glycoprotein carbohydrate antigen 125 (CA125) has been proposed as a new biomarker in heart failure (HF). Its potential prognostic role in chronic (CHF) and acute HF (AHF) is still underrecognized.
Claudia Josa-Laorden, Ignacio Giménez-López, Charles Butcher, Marta Sánchez, José Rubio-Gracia, Juan I. Pérez-Calvo   +5 more
doaj   +1 more source

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer

Open Medicine, 2016
To evaluate the value of individual and combined measurement of human epididymis protein 4 (HE4) and cancer antigen 125 (CA-125) in the diagnosis of ovarian cancer.
Zheng Li-e, Qu Jun-ying, He Fei
doaj   +1 more source

Systemic Inflammatory Response Markers Associated with Infertility and Endometrioma or Uterine Leiomyoma in Endometriosis

Therapeutics and Clinical Risk Management, 2020
Xuanxuan Jing,1,* Chen Li,1,2,* Jintang Sun,1 Jin Peng,3 Yu Dou,4 Xiaofei Xu,3 Chao Ma,1 Zhaogang Dong,5 Yanguo Liu,6 Hui Zhang,3 Qianqian Shao,1 Hui Zhang,7 Lijie Wang,3 Yun Zhang,1 Xun Qu1 1Institute of Basic Medical Sciences, Key Laboratory of ...
Jing X, Li C, Sun J, Peng J, Dou Y, Xu X, Ma C, Dong Z, Liu Y, Zhang H, Shao Q, Zhang H, Wang L, Zhang Y, Qu X   +14 more
doaj  

The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity

Diagnostics, 2022
Lung cancer is the second most commonly diagnosed cancer in the world. In terms of the diagnosis of lung cancer, combination carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) detection had higher sensitivity, specificity, and diagnostic odds ...
Hebatallah M. Saad, Ghada F. Tourky, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ahmed M. Khattab, Sohaila A. Elmasry, Abdulrahman A. Alsayegh, Zaki H. Hakami, Ahmad Alsulimani, Jean-Marc Sabatier, Marwa W. Eid, Hazem M. Shaheen, Ali A. Mohammed, Gaber El-Saber Batiha, Michel De Waard   +14 more
doaj   +1 more source

CA125: Holy Grail or a Poisoned Chalice [PDF]

Nephron Clinical Practice, 2005
The history of (and perhaps the lessons to be learned from) peritoneal CA125 investigation presents no better example of the diffi culties in assigning the status of a ‘marker’ predictive of membrane dysfunction to factors measured in dialysis effl uent. In 1995, Visser et al. [3] were the fi rst to suggest that CA125 could be used as ‘a bulk marker of
Nicholas, Topley, Daryn, Michael, Timothy, Bowen   +2 more
openaire   +2 more sources

Analyzing the Role of CA125 in the Care of Patients with Epithelial Ovarian Cancer [PDF]

Batna Journal of Medical Sciences
Background: Ovarian cancer is the most lethal gynecological malignancy, often diagnosed at advanced stages due to asymptomatic presentation. The CA125 tumor marker plays a crucial role in the diagnosis and management of this disease.
Dalal ZERROUK, Habiba HEMAMID, Nadji BOUGHABA, Hichem El Azhari BENMAMAR, Youcef KHENCHOUL, Ines BOUKERZAZA, Taha FILALI   +6 more
doaj   +1 more source

A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk

Journal of Comparative Effectiveness Research, 2023
Aim: This largest-of-its-kind study evaluated the clinical utility of CA125 and OVA1, commonly used as ovarian tumor markers for assessing the risk of malignancy.
Gerard P Reilly, David A Gregory, Dennis J Scotti, Samuel Lederman, Wade A Neiman, Steven Sussman, Lisa M Bean, Mercedes M Ekono   +7 more
doaj   +1 more source